UBS Group AG - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$18,000
+125.0%
61,710
+157.6%
0.00%
Q4 2021$8,000
-42.9%
23,953
+20.5%
0.00%
Q3 2021$14,000
+250.0%
19,874
+610.3%
0.00%
Q4 2020$4,000
+300.0%
2,798
+210.2%
0.00%
Q2 2020$1,000
-85.7%
902
-89.0%
0.00%
Q4 2019$7,000
-41.7%
8,187
-51.2%
0.00%
Q3 2019$12,000
+500.0%
16,781
+752.3%
0.00%
Q1 2019$2,000
+100.0%
1,969
+110.6%
0.00%
Q4 2018$1,0009350.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,851,851$951,0000.11%
BVF INC/IL 3,217,480$1,654,0000.09%
NEA Management Company, LLC 2,052,455$1,055,0000.04%
McGuire Investment Group, LLC 24,000$12,0000.00%
WEDBUSH SECURITIES INC 70,204$36,0000.00%
GRIMES & COMPANY, INC. 23,998$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,200$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 64,347$33,0000.00%
MILLENNIUM MANAGEMENT LLC 49,497$25,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders